We are live on
!
Find out more
MC
Montag & Caldwell Portfolio holdings
AUM
$457M
1-Year Est. Return
20.19%
This Fund
S&P 500
This Quarter
Est. Return
-1.28%
1 Year Est. Return
+20.19%
3 Year Est. Return
+91.25%
5 Year Est. Return
+132.5%
10 Year Est. Return
+417.29%
AUM
$4.14B
AUM Growth
-$622M
(-13%)
Cap. Flow
-$540M
Cap. Flow
% of AUM
-13.07%
Top 10 Holdings %
Top 10 Hldgs %
42.71%
Holding
97
New
6
Increased
40
Reduced
30
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$165M |
| 2 |
UnitedHealth
UNH
|
+$162M |
| 3 |
Edwards Lifesciences
EW
|
+$140M |
| 4 |
Fidelity National Information Services
FIS
|
+$89.3M |
| 5 |
Estee Lauder
EL
|
+$50.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$121M |
| 2 |
Medtronic
MDT
|
+$106M |
| 3 |
AGN
Allergan plc
AGN
|
+$98.9M |
| 4 |
Occidental Petroleum
OXY
|
+$79.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.14% |
| 2 | Consumer Staples | 24.22% |
| 3 | Technology | 15.65% |
| 4 | Financials | 10.17% |
| 5 | Communication Services | 9.07% |
Similar funds
PA
NC
JWCA
TFF
WWP
FGC
CF
SFA
Montag & Caldwell's Q4 2016 Portfolio in Review
As of Q4 2016, Montag & Caldwell held 97 positions worth $4.14B, down 13% from $4.76B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Montag & Caldwell withdrew a net $540M in Q4 2016, closing 11 positions and reducing 30 holdings. Its most notable exit was Amgen, an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Montag & Caldwell opened a new position in UnitedHealth worth $174M.
- Montag & Caldwell's largest Q4 2016 buy was UnitedHealth: 1,084,708 shares worth $174M.
- Montag & Caldwell added most to Microsoft in Q4 2016, an estimated $165M increase.
- Montag & Caldwell's biggest Q4 2016 reduction was Medtronic, cutting an estimated $106M.
- Montag & Caldwell fully exited Amgen in Q4 2016, selling an estimated $121M.
- Montag & Caldwell's ten largest holdings make up 43% of its $4.14B portfolio in Q4 2016.
- Montag & Caldwell opened 6 new positions and closed 11 in Q4 2016.
- Montag & Caldwell's portfolio value fell 13% quarter-over-quarter to $4.14B.
Based on Montag & Caldwell's 13F filing for Q4 2016, filed 7 Feb 2017.